Bachem Holding AG

SWX:BANB Stock Report

Market Cap: CHF 5.9b

Bachem Holding Future Growth

Future criteria checks 3/6

Bachem Holding is forecast to grow earnings and revenue by 15.7% and 17.3% per annum respectively. EPS is expected to grow by 16.6% per annum. Return on equity is forecast to be 14.2% in 3 years.

Key information

15.7%

Earnings growth rate

16.60%

EPS growth rate

Life Sciences earnings growth19.2%
Revenue growth rate17.3%
Future return on equity14.24%
Analyst coverage

Good

Last updated08 May 2026

Recent future growth updates

Recent updates

Narrative Update • May 22

BANB: Higher Assumed Growth Will Exacerbate Execution Risk And Limit Upside

Analysts have nudged their price targets for Bachem Holding higher, with recent Street research citing revised assumptions for growth, margins and P/E that collectively support a modestly higher fair value approach in CHF terms. Analyst Commentary Recent price target revisions for Bachem Holding sit in a fairly tight range, with updates clustered around the CHF 80 level.
Narrative Update • May 01

BANB: Future Earnings Execution Is Expected To Support CHF 80 Upside Potential

Analysts have nudged their price target on Bachem Holding slightly higher, with recent Street research indicating a CHF 5 increase from both Barclays and Deutsche Bank to CHF 80, supported by updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a CHF 80 target as aligned with their updated view on fair value, suggesting that current assumptions on growth and margins justify a higher valuation anchor.
New Narrative • Apr 26

Bachem Holding - The Purest Public Peptide Play?

We are living through a biological revolution. You see it on the balance sheets of the world’s largest pharmaceutical companies and you see it in the cultural zeitgeist.
Narrative Update • Apr 16

BANB: Future Upside Will Depend On Executing Profit Margin Assumptions

Narrative Update Bachem Holding's updated analyst price target now reflects a modest recalibration in assumptions, with recent CHF 5, CHF 80, and CHF 32 target increases cited by analysts who point to slightly higher profit margin expectations and a small adjustment to the assumed P/E multiple as key drivers. Analyst Commentary Recent research updates on Bachem Holding have leaned constructive, with bullish analysts adjusting their price targets upward and citing a mix of valuation and execution factors.
Narrative Update • Apr 02

BANB: Future Execution On Project Pipeline Will Support CHF 80 Upside Potential

Narrative Update Analyst price targets for Bachem Holding have shifted to a range of CHF 60 to CHF 80, with the upper end raised from CHF 75, as analysts reflect updated views on the company in their valuation work. Analyst Commentary Recent research updates on Bachem Holding point to a split in how analysts see the risk and reward around the stock, which feeds directly into the current CHF 60 to CHF 80 price target range.
Narrative Update • Mar 19

BANB: Future Execution On Growth Plans Will Support Higher CHF 80 Upside Potential

Analysts have nudged the consolidated price target for Bachem Holding to CHF 80, up CHF 5 from prior levels, citing updated assumptions for growth, profitability and a slightly lower P/E outlook that align with recent Street research moves. Analyst Commentary Street research on Bachem Holding has been mixed, with some analysts lifting price targets toward CHF 80 while others are more hesitant and keep targets closer to CHF 60.
Narrative Update • Mar 05

BANB: Future Execution On Pipeline Plans Will Support Higher Market Confidence

The updated analyst price target for Bachem Holding suggests a modest upward revision to fair value to CHF 78.66, with analysts citing slightly adjusted assumptions for the discount rate, revenue growth, profit margins, and future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts point to the higher price target as a signal that their assumptions for Bachem Holding’s future earnings and cash flows now support a fair value above the prior level, even after revisiting discount rate and P/E inputs.
Narrative Update • Feb 18

BANB: Future Pipeline Execution Will Drive Upside Versus Recent Cautious Views

Analysts have adjusted their fair value estimate for Bachem Holding to CHF 76.59, reflecting updated views on growth, profitability and valuation following recent price target revisions that include a CHF 32 increase from RBC Capital and a reduction to CHF 60 from Barclays. Analyst Commentary Recent research shows a split view on Bachem Holding, with some bullish analysts lifting targets and more cautious voices trimming expectations.
Narrative Update • Feb 04

BANB: Higher Fair Value Will Rely On Execution Of Existing Order Book

Analysts have raised their fair value estimate for Bachem Holding from CHF 100.00 to CHF 110.00, citing updated assumptions around revenue growth, profit margins and future P/E multiples that are in line with recent Street target changes, including the higher price target from RBC and the revised level from Barclays. Analyst Commentary Recent research updates around Bachem Holding give you a mixed but useful read on how the Street is thinking about valuation and execution.
Narrative Update • Jan 21

BANB: Building K Execution Risks Will Limit Future Share Upside

Analysts have nudged their price target on Bachem Holding slightly lower to about CHF 60 to CHF 75, reflecting updated assumptions around discount rates, revenue growth near 21.5% and an expected future P/E close to 18.9%. They are also weighing recent research that includes a reduced CHF 60 target alongside a CHF 75 target tied to the company’s Building K expansion plans.
Narrative Update • Jan 07

BANB: Building K Execution Risk Will Constrain Future Upside Potential

Analysts have trimmed their average price target on Bachem Holding to CHF 60 from CHF 75, citing updated assumptions for revenue growth, profit margins and future P/E multiples that reflect a more measured outlook, even as expansion projects remain in focus. Analyst Commentary Recent street research on Bachem highlights a mix of views, with some analysts seeing potential tied to expansion projects such as Building K, while others are recalibrating expectations and price targets to reflect what they view as a more balanced risk and reward profile.
Narrative Update • Dec 14

BANB Building K Expansion Will Define Future Upside And Execution Risk

Analysts have raised their price target for Bachem Holding from approximately CHF 58 to about CHF 75, citing increased confidence in revenue growth driven by the company's Building K expansion project, despite a slightly higher discount rate and modestly lower profit margin and valuation multiples. Analyst Commentary Recent research commentary highlights a more constructive stance on Bachem Holding, with the upgraded price target to CHF 75 framed around the growth potential from the Building K expansion project.
Analysis Article • Dec 01

At CHF51.85, Is Bachem Holding AG (VTX:BANB) Worth Looking At Closely?

While Bachem Holding AG ( VTX:BANB ) might not have the largest market cap around , it received a lot of attention from...
Analysis Article • Oct 25

Bachem Holding AG's (VTX:BANB) Price In Tune With Earnings

Bachem Holding AG's ( VTX:BANB ) price-to-earnings (or "P/E") ratio of 32x might make it look like a strong sell right...
Narrative Update • Sep 26

Building K Production Will Serve Peptide And Oligonucleotide Therapies

Bachem Holding's fair value has been revised downward, primarily reflecting slight declines in both its discount rate and future P/E ratio, with the consensus analyst price target decreasing from CHF77.88 to CHF74.70. What's in the News Maintained 2026 sales guidance of over CHF 1 billion and profitability above 30%.
Analysis Article • Sep 18

Bachem Holding (VTX:BANB) Ticks All The Boxes When It Comes To Earnings Growth

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Analysis Article • Aug 16

Bachem Holding (VTX:BANB) Seems To Use Debt Quite Sensibly

SWX:BANB 1 Year Share Price vs Fair Value Explore Bachem Holding's Fair Values from the Community and select yours Some...
Analysis Article • Jul 30

Bachem Holding's (VTX:BANB) Profits May Not Reveal Underlying Issues

The market for Bachem Holding AG's ( VTX:BANB ) stock was strong after it released a healthy earnings report last week...
Analysis Article • Jul 25

Bachem Holding AG's (VTX:BANB) P/E Is Still On The Mark Following 28% Share Price Bounce

Bachem Holding AG ( VTX:BANB ) shares have continued their recent momentum with a 28% gain in the last month alone. But...
User avatar
New Narrative • Mar 02

Building K And 24-Hour Operations Will Improve Efficiency

Capacity expansion and 24/7 operations enhance production, reduce costs, and bolster revenue growth in response to rising demand for peptides and oligonucleotides.

Earnings and Revenue Growth Forecasts

SWX:BANB - Analysts future estimates and past financials data (CHF Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20281,355260-1023138
12/31/20271,159227-1642408
12/31/2026958186-2291616
12/31/2025695149-58272N/A
9/30/2025687141-95208N/A
6/30/2025678134-133144N/A
3/31/2025642127-136145N/A
12/31/2024605120-138146N/A
9/30/2024592117-96195N/A
6/30/2024578114-53244N/A
3/31/2024578113-36247N/A
12/31/2023577112-19250N/A
9/30/2023557105-40193N/A
6/30/202353799-62137N/A
3/31/2023534100-56115N/A
12/31/2022532101-5093N/A
9/30/202251599-4791N/A
6/30/202249998-4488N/A
3/31/2022501106-3293N/A
12/31/2021503115-1998N/A
9/30/20214841071107N/A
6/30/20214649821116N/A
3/31/20214338834116N/A
12/31/20204027846115N/A
9/30/20203797247103N/A
6/30/2020356674791N/A
3/31/2020335604178N/A
12/31/2019314543464N/A
9/30/201931052N/A60N/A
6/30/201930651N/A57N/A
3/31/201929449N/A41N/A
12/31/201828347N/A26N/A
9/30/201826845N/A24N/A
6/30/201825342N/A23N/A
3/31/201825742N/A30N/A
12/31/201726242N/A36N/A
9/30/201725241N/A36N/A
6/30/201724240N/A35N/A
3/31/201723941N/A38N/A
12/31/201623641N/A40N/A
9/30/201622939N/A46N/A
6/30/201622236N/A52N/A
3/31/201621634N/A57N/A
12/31/201520932N/A61N/A
9/30/201520331N/A59N/A
6/30/201519729N/A57N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BANB's forecast earnings growth (15.7% per year) is above the savings rate (0.6%).

Earnings vs Market: BANB's earnings (15.7% per year) are forecast to grow faster than the Swiss market (10.9% per year).

High Growth Earnings: BANB's earnings are forecast to grow, but not significantly.

Revenue vs Market: BANB's revenue (17.3% per year) is forecast to grow faster than the Swiss market (4.9% per year).

High Growth Revenue: BANB's revenue (17.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BANB's Return on Equity is forecast to be low in 3 years time (14.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/25 19:43
End of Day Share Price 2026/05/22 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bachem Holding AG is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charles PitmanBarclays
Charles PitmanBarclays
Estelle BétriseyBerenberg